Independent Reviews, DOJ Scrutiny, and 2026 Guidance in Focus
December 22, 2025 — UnitedHealth Group Incorporated (NYSE: UNH) is ending the year with investors focused less on “normal” quarterly momentum and more on a three-part storyline that could shape how the market values the healthcare giant in 2026: (1) management’s operational overhaul after independent reviews, (2) a heavy regulatory and legal backdrop, and (3) the next earnings call—when the company will finally lay out full-year 2026 guidance.
As of Dec. 22, UNH shares were trading around $325 in U.S. trading, leaving the stock well below its highs and keeping UnitedHealth near the top of the list of “show-me” large caps for 2026.
UnitedHealth stock today: where UNH is trading on Dec. 22, 2025
UnitedHealth stock (UNH) was…
